You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 461 Updated PFS analysis of toripalimab with anlotinib and chemotherapy as first-line therapy in patients with extensive-stage small-cell lung cancer (ES-SCLC)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
461 Updated PFS analysis of toripalimab with anlotinib and chemotherapy as first-line therapy in patients with extensive-stage small-cell lung cancer (ES-SCLC)
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to September 2024

AbstractFullPdf
Nov 2021299024
Dec 20217003
Jan 20226608
Feb 20226805
Mar 202219205
Apr 20227807
May 202260012
Jun 20222807
Jul 20222603
Aug 20222806
Sep 20225409
Oct 202260010
Nov 20222206
Dec 20221400
Jan 20232404
Feb 20231802
Mar 2023401
Apr 20232608
May 20232402
Jun 20232405
Jul 202324010
Aug 20231606
Sep 20232602
Oct 20231206
Nov 202338089
Dec 20233403
Jan 20242003
Feb 20243402
Mar 20241807
Apr 20241002
May 20241801
Jun 20241600
Jul 20243604
Aug 2024902
Sep 20241203
Total15080267